ACM
HURA

Aster Capital Management’s TuHURA Biosciences HURA Stock Holding History

Aster Capital Management’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$210K Buy
+89,690
New +$209K 0.04% 405

Other funds holding HURA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Aster Capital Management's HURA Position: Q2 2026 in Review

Aster Capital Management opened a new position in TuHURA Biosciences (HURA) in Q2 2026: 89,690 shares worth $210K. The stake represents 0.04% of the portfolio and ranks #405 among its holdings.

90 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

  • Aster Capital Management held 89,690 shares of TuHURA Biosciences worth $210K as of Q2 2026.
  • TuHURA Biosciences was a new Aster Capital Management position in Q2 2026.
  • TuHURA Biosciences made up 0.04% of Aster Capital Management's portfolio in Q2 2026, its #405 holding.
  • 90 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.